MyFinsight
Home
Blog
About
Contact
Download
Download image
Impairment
$7,311M
(56138.46%↑ Y/Y)
Sales and maturities
of investments
$5,780M
(-0.09%↓ Y/Y)
Medical claims
liabilities
$2,336M
(534.78%↑ Y/Y)
Premium and trade
receivables
-$1,480M
(-134.16%↓ Y/Y)
Depreciation and
amortization
$1,275M
(2.74%↑ Y/Y)
Stock compensation
expense
$204M
(-3.77%↓ Y/Y)
Unearned revenue
$80M
(248.15%↑ Y/Y)
Other operating
activities, net
$75M
(33.93%↑ Y/Y)
Net cash provided by
operating activities
$5,088M
(3203.90%↑ Y/Y)
Net cash provided by
(used in) investing...
$472M
(144.87%↑ Y/Y)
Canceled cashflow
$7,673M
Canceled cashflow
$5,308M
Net increase
(decrease) in cash, cash...
$3,939M
(219.51%↑ Y/Y)
Canceled cashflow
$1,621M
Net earnings (loss)
-$6,677M
(-302.70%↓ Y/Y)
Accounts payable and
accrued expenses
-$657M
(-24.43%↓ Y/Y)
Other assets
$230M
(600.00%↑ Y/Y)
Deferred income taxes
-$60M
(-561.54%↓ Y/Y)
Other long-term
liabilities
-$46M
(34.29%↑ Y/Y)
(gain) loss on
divestitures, net
$2M
(-98.33%↓ Y/Y)
(gain) on debt
extinguishment
$1M
Proceeds from long-term
debt
$750M
(-42.31%↓ Y/Y)
Proceeds from common
stock issuances
$37M
(-19.57%↓ Y/Y)
Purchases of investments
$4,541M
(-36.78%↓ Y/Y)
Capital expenditures
$767M
(19.10%↑ Y/Y)
Net cash used in
financing activities
-$1,621M
(32.63%↑ Y/Y)
Canceled cashflow
$787M
Payments and repurchases
of long-term debt
$1,895M
(204.66%↑ Y/Y)
Common stock
repurchases
$475M
(-84.80%↓ Y/Y)
Other financing
activities, net
-$19M
(-216.67%↓ Y/Y)
Purchase of
noncontrolling interest
$19M
Back
Back
Cash Flow
source: myfinsight.com
centene_logo_white-svg
CENTENE CORP (CNC)
centene_logo_white-svg
CENTENE CORP (CNC)